Genentech

POLIVY

Manufacturer:

Genentech

Polivy HCPCS:

J9309

HCPCS Code Descriptor:

Injection, polatuzumab vedotin-piiq, 1 mg

Category:

J Code

Polivy NDCs:

50242-0103-01, 50242-0105-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Polivy CPT Codes:

Potential CPT administration codes for Polivy can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Polivy:

POLIVY is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9309 is aligned to the drug POLIVY.

ACCESS PRICING AND MORE BY REGISTERING

J9309 Added Date:

January 1, 2020

J9309 Effective Date:

January 1, 2020

J9309 Termination Date:

HCPCS Active

Polivy billing and coding information can be found through Genentech at the link below:
Polivy patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
POLIVY prescribing information can be found at the link below:
Information regarding POLIVY’s side effects can be found at MedlinePlus